A Mutation in Yeast TOP2 Homologous to a Quinolone-resistant Mutation in Bacteria
Open Access
- 1 September 1995
- journal article
- Published by Elsevier BV
- Vol. 270 (35), 20359-20364
- https://doi.org/10.1074/jbc.270.35.20359
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Major Advances in Antibacterial Quinolone TherapyPublished by Elsevier BV ,1994
- Roles of DNA Topoisomerases in Chromosomal Replication and SegregationPublished by Elsevier BV ,1994
- Drug features that contribute to the activity of quinolones against mammalian topoisomerase II and cultured cells: correlation between enhancement of enzyme-mediated DNA cleavage in vitro and cytotoxic potentialAntimicrobial Agents and Chemotherapy, 1993
- When good enzymes go bad: Conversion of topoisomerase II to a cellular toxin by antineoplastic drugsChemical Research in Toxicology, 1993
- Effects of novel fluoroquinolones on the catalytic activities of eukaryotic topoisomerase II: Influence of the C-8 fluorine groupAntimicrobial Agents and Chemotherapy, 1992
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Inhibitors of DNA topoisomerasesBiochemistry, 1988
- DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombeCell, 1987
- Recent studies of DNA topoisomerasesBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1987
- DNA topoisomerase II is required at the time of mitosis in yeastCell, 1985